Pentoxifylline versus prednisolone for severe alcoholic hepatitis: A randomized controlled trial

Table 3 Morbidity/complication profile of patients receiving pentoxifylline (group I) or prednisolone (group II) in the treatment of severe alcoholic hepatitis

Complications	Duration of follow-up
	0-3 mo		3 mo to 1 yr
	Group I (n = 34)	Group II (n = 34)	Group I (n = 29)	Group II (n = 22)
Nausea	24	19	14	4
Vomiting	12	8	4	1
Dyspepsia	3	7	1	1
GI bleed	-	2	2	4
Oral thrush	-	6	-	-
Sepsis	2	2		3
Recurrent encephalopathy	2	-	5	-
Worsening ascites	-	2	-	2
Impaired glucose tolerance	-	2	-	2
Delayed wound healing	-	2	-	1
Deep vein thrombosis	-	1	-	-
Pancreatitis	-	1	-	-
Hepatorenal syndrome	-	6	-	-